De-escalation: Clinical Trials

4 trials for De-escalation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 recruiting. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Unknown 2, Recruiting 1

Follow De-escalation: new trials by email Literature Review of De-escalation trials Research Report on De-escalation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer
primary RPLND for low-stage metasatatic seminoma, 3 courses of chemotherapy; Blemocin, Etoposide and Platinum (BEP) - Testicular Cancer, Seminoma
Not applicableRecruitingSahlgrenska University Hospital1602026-03-192026-03-27
Toripalimab Based Induction Chemotherapy Followed by De-escalation Protocols in HPV-related OPSCC
Toxicities reduced treatment arm - Oropharyngeal Carcinoma, Immune Checkpoint Inhibitor
Not applicableUnknownFudan University462021-02-012021-04-30
De-escalation Protocols in HPV-related Oropharyngeal Carcinoma in Chinese Populations
Toxicities reduced treatment, conventional treatment - Oropharyngeal Carcinoma, De-escalation
Not applicableUnknownFudan University832019-07-012019-07-09
Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)
Qualitative Interview or Focus group discussions - Decision Making ,Shared, De-escalation
CompletedUniversity of Alabama at Birmingham2002017-06-272026-02-23

Narrower conditions

Oropharyngeal Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Seminoma (1)  ·  Testicular Neoplasms (1)

Broader conditions

Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Head and Neck Neoplasms (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Otorhinolaryngologic Neoplasms (2)  ·  Pharyngeal Diseases (2)  ·  Pharyngeal Neoplasms (2)  ·  Stomatognathic Diseases (2)  ·  Breast Diseases (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Genital Neoplasms, Male (1)  ·  Germinoma (1)

Interventions

Bleomycin (1)  ·  Etoposide (1)  ·  Neoadjuvant Therapy (1)  ·  Platinum (1)

Sponsors

Fudan University (2)  ·  Sahlgrenska University Hospital (1)  ·  University of Alabama at Birmingham (1)

Countries

China (2)  ·  Sweden (1)  ·  United States (1)

Top investigators

Chaosu Hu, MD (1)  ·  Gabrielle B Rocque, MD (1)

Results publications

PMID 36215065, PMID 39341091